Sufferers of multiple sclerosis (MS), an autoimmune disease that can attack the central nervous system will be excited to hear news that recently released results of a five-year study have revealed a promising new treatment for relapsing-remitting MS.
The new treatment, known as “high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT)” has shown that 69 percent of trial participants survived with no worsening of the disease and with no relapse of MS symptoms.
A reasonably simple procedure requires the doctor extract blood-forming stem cells from the patient. Then drain the immune system via chemotherapy before returning the patient’s own stem cells with the intended effect of reconstructing the immune system over with healthier cells. Some study participants did experience infections, so the treatment is not without risks.
While additional, larger research and testing will be appropriate, these results are encouraging. Assuming similar results, MS victims who have not been responsive to currently available therapies, may have an alternative to help them avoid relapsing-remitting MS.
Dr. Shiva Gopal Vasishta who makes his home in Voorhees, New Jersey is a board-certified neurologist interested in this new treatment option. Practicing for over 20 years, Dr. Vasishta received his medical degree from Government Medical College Nagpur in 1979. Boston City Hospital, was honored to have Dr. Gopal Vasishta, who also specializes in Psychiatry, complete his residency at their facility. Currently practicing at Eastern Neurodiagnostic Associates, Dr. Vasishta is affiliated with Kennedy Health System Cherry Hill Campus and his office is friendly to both English and Spanish speaking patients.
Medical professionals who specialize in neurology diagnose and treat brain, spinal cord, peripheral nerve, and muscle disorders. Involuntary nervous systems that control hearts, lungs and other organs also fall under Dr. Gopal Vasishta’s expertise along with headaches, stroke, dementia, seizures, epilepsy, sleep disorders and neuromuscular diseases.